🚀NASA's Notice to Grant Patent License
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More📜Notice of Intent to Grant Exclusive Patent License by Air Force
Pursuant to the Bayh-Dole Act and implementing regulations, the Department of the Air Force hereby gives notice of its intent to grant an exclusive patent license agreement to The University of Cincinnati, a State of Ohio institute of higher education, having a place of business at 2900 Reading Road, Suite 460, Cincinnati, OH 45206-0829.
Learn More💡NSF Breakthrough Innovations Initiative
The National Science Foundation (NSF) is announcing plans to renew this collection. In accordance with the requirements of the Paperwork Reduction Act of 1995, we are providing this opportunity for public comment on this action. After obtaining and considering public comment, NSF will prepare the submission requesting Office of Management and Budget (OMB) clearance of this collection for no longer than 3 years.
Learn More🛠️Notice of Intent to Grant Exclusive Patent License to ColdQuanta
Pursuant to the Bayh-Dole Act and implementing regulations, the Department of the Air Force hereby gives notice of its intent to grant an exclusive patent license to ColdQuanta, Inc., a Delaware corporation dba Infleqtion, having a place of business at 3030 Sterling Cir., Boulder, CO 80301-2338.
Learn More💡NSF Seeks Input on Key Technology Focus Areas for Innovation
The U.S. National Science Foundation seeks input from academia, non-profits, philanthropy, state and local government, venture capital, the private sector and any other interested parties to inform the agency's assessment and potential update of the Key Technology Focus Areas as described in Public Law 117-167 (Research and Development, Competition, and Innovation Act.)
Learn More🛠️NASA's Intent to Grant Exclusive Patent Licenses
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
Learn More💉Government-Owned Invention Licensing Notice for Norovirus Antibody
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Learn More💡Government-Owned Inventions Available for Licensing in Healthcare
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Learn More🧬Government-Owned Inventions Available for Licensing in Biomedical Research
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research for the benefit of the public health.
Learn More💉Government-Owned Invention Licensing Opportunity in Health
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Learn More